| Name | Title | Contact Details |
|---|
HPA is a medical fitness industry leader that consults, creates, and manages clinically integrated medical wellness facilities.
Pride Mobility Products® Corporation is the worlds leading designer and manufacturer of mobility products including Jazzy® Power Chairs, Go-Go® Travel Mobility, Pride® Mobility Scooters, Pride® Power Lift Recliners, and Pride® Lifts and Ramps. The Pride family of companies also includes Quantum Rehab®, a leader in complex rehab power chairs with the Q6 Edge® 2.0, 4Front™, and Q6 Series of power bases, TRU-Balance® 3 Power Positioning Systems, and Q-Logic 3 Advanced Drive Controls, as well as Stealth Products®, the foremost manufacturer of positioning components. Headquartered in Exeter, Pennsylvania, Pride also has operations in Australia, Canada, China, Italy, the Netherlands, New Zealand, and the United Kingdom. Pride is dedicated to providing expertly designed, engineered, and tested products incorporating technologically innovative features enabling consumers to achieve the highest quality of life and mobility goals. Pride helps millions of people live their lives to the fullest by creating the best personal mobility products in the world. Pride’s products serve the widest range of mobility needs, with a family of brands that are industry leaders in changing lives. Our employees are treated with respect and provided with an equal opportunity to contribute to the success of our company and their own personal growth. Pride Mobility Products Corporation is an Equal Opportunity/Affirmative Action employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or protected Veteran status.
Reimbursement Concepts is a Weirton, WV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At MELA Sciences, we design and develop innovative software-driven medical technologies for physician clinical use during the detection of skin cancers at the most curable and cost-effective stages. Our mission is to develop breakthrough medical technologies to improve skin cancer detection and achieve better outcomes for all. We envision a world in which our pioneering innovations will change the way patients think about skin cancer, while providing dermatologists and clinicians with new, effective, non-invasive tools for the earliest detection possible. MELA Sciences conducted the largest, positive prospective study ever done on the melanoma disease, and is the first and only medical technology company to receive both FDA Pre-Market Approval (PMA) for the U.S. and CE Marking certification for the European Union for a device of this nature. The company’s flagship product, MelaFind®, is intended to provide dermatologists with software-driven image analysis of clinically atypical pigmented skin lesions when they choose to obtain additional information to help decide whether to biopsy or not. The FDA has approved MELA Sciences’ MelaFind® Pre-Market Approval application for use in the United States and MELA Sciences has also been granted CE Mark approval for sale of MelaFind® in the European Union.
Aldie Foundation Inc is a Doylestown, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.